https://www.selleckchem.com/products/ca77-1.html
BACKGROUND AIMS For patients with liver disease from hepatitis C virus (HCV) infection complicated by end-stage renal disease (ESRD), it is important to assess liver fibrosis before kidney transplantation. We evaluated the accuracy of non-invasive tests to identify advanced hepatic fibrosis in patients with HCV and ESRD. METHODS In a retrospective study, we collected data on ratio of aspartate aminotransferasealanine aminotransferase (ASTALT), AST platelet ratio index (APRI), FIB-4 score, fibrosis index score, and King's score from
Like
Comment
Share
